As of January 2025, Orient EuroPharma has a market cap of $127.87M. This makes Orient EuroPharma the world's 18521th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $103.46M | 0.26% |
2023 | $103.20M | 7.46% |
2022 | $96.04M | -0.41% |
2021 | $96.43M | -24.43% |
2020 | $127.61M | -13.49% |
2019 | $147.50M | 6.72% |
2018 | $138.22M | -34.13% |
2017 | $209.85M | 27.58% |
2016 | $164.48M | 3.68% |
2015 | $158.64M | -14.57% |
2014 | $185.70M | -19.72% |
2013 | $231.33M | 80.35% |
2012 | $128.27M | 48.09% |
2011 | $86.62M | -41.06% |
2010 | $146.97M | 3.65% |
2009 | $141.79M | 46.91% |
2008 | $96.52M | 49.34% |
2007 | $64.63M | - |